메뉴 건너뛰기




Volumn 22, Issue 1, 2016, Pages e71-e74

Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; VON WILLEBRAND FACTOR; BLOOD CLOTTING FACTOR 8; DRUG COMBINATION; FACTOR VIII, VON WILLEBRAND FACTOR DRUG COMBINATION;

EID: 84958926068     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12857     Document Type: Letter
Times cited : (7)

References (10)
  • 1
    • 84958888667 scopus 로고    scopus 로고
    • Committee for Medicinal Products for Human Use (CHMP). Reflection paper on Immune Tolerance Induction in haemophilia A patients with inhibitors. EMA/CHMP/BPWP/153137/2011.
    • Accessed September 4
    • European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). Reflection paper on Immune Tolerance Induction in haemophilia A patients with inhibitors. EMA/CHMP/BPWP/153137/2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/03/WC500140787.pdf.2011. Accessed September 4, 2015.
    • (2015)
  • 2
    • 34248220822 scopus 로고    scopus 로고
    • Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors
    • Astermark J, Morado M, Rocino A et al. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors. Haemophilia 2006; 12: 363-71.
    • (2006) Haemophilia , vol.12 , pp. 363-371
    • Astermark, J.1    Morado, M.2    Rocino, A.3
  • 3
    • 34347360724 scopus 로고    scopus 로고
    • International workshop on immune tolerance induction: consensus recommendations
    • DiMichele DM, Hoots WK, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: consensus recommendations. Haemophilia 2007; 13(Suppl 1): 1-22.
    • (2007) Haemophilia , vol.13 , pp. 1-22
    • DiMichele, D.M.1    Hoots, W.K.2    Pipe, S.W.3    Rivard, G.E.4    Santagostino, E.5
  • 4
    • 34447287337 scopus 로고    scopus 로고
    • Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response
    • Gringeri A, Musso R, Mazzucconi MG et al. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Haemophilia 2007; 13: 373-9.
    • (2007) Haemophilia , vol.13 , pp. 373-379
    • Gringeri, A.1    Musso, R.2    Mazzucconi, M.G.3
  • 5
    • 84856866914 scopus 로고    scopus 로고
    • The principal results of the International Immune Tolerance Study: a randomized dose comparison
    • Hay CR, DiMichele DM. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood 2012; 119: 1335-44.
    • (2012) Blood , vol.119 , pp. 1335-1344
    • Hay, C.R.1    DiMichele, D.M.2
  • 6
    • 84890858676 scopus 로고    scopus 로고
    • Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate
    • Oldenburg J, Jimenez-Yuste V, Peiro-Jordan R, Aledort LM, Santagostino E. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate. Haemophilia 2014; 20: 83-91.
    • (2014) Haemophilia , vol.20 , pp. 83-91
    • Oldenburg, J.1    Jimenez-Yuste, V.2    Peiro-Jordan, R.3    Aledort, L.M.4    Santagostino, E.5
  • 7
    • 84925954257 scopus 로고    scopus 로고
    • Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product
    • Rangarajan S, Jimenez-Yuste V, Santagostino E. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product. Haemophilia 2014; 20: e414-17.
    • (2014) Haemophilia , vol.20 , pp. e414-e417
    • Rangarajan, S.1    Jimenez-Yuste, V.2    Santagostino, E.3
  • 8
    • 80055106986 scopus 로고    scopus 로고
    • The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
    • Kurth M, Puetz J, Kouides P et al. The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience. J Thromb Haemost 2011; 9: 2229-34.
    • (2011) J Thromb Haemost , vol.9 , pp. 2229-2234
    • Kurth, M.1    Puetz, J.2    Kouides, P.3
  • 9
    • 70449591451 scopus 로고    scopus 로고
    • Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate
    • Diez JM, Caballero S, Belda FJ, Otegui M, Gajardo R, Jorquera JI. Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate. Haemophilia 2009; 15: 1249-57.
    • (2009) Haemophilia , vol.15 , pp. 1249-1257
    • Diez, J.M.1    Caballero, S.2    Belda, F.J.3    Otegui, M.4    Gajardo, R.5    Jorquera, J.I.6
  • 10
    • 44649136183 scopus 로고    scopus 로고
    • The role of VWF for the success of immune tolerance induction
    • Kreuz W. The role of VWF for the success of immune tolerance induction. Thromb Res 2008; 122(Suppl 2): S7-12.
    • (2008) Thromb Res , vol.122 , pp. S7-12
    • Kreuz, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.